Lv3
320 积分 2021-08-09 加入
China ARCHES: A Phase 3 Trial of Enzalutamide vs Placebo in Metastatic Hormone-Sensitive Prostate Cancer
1个月前
已关闭
Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
4个月前
已完结
Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma
4个月前
已完结
Atezolizumab and bevacizumab for HCC in the real world
4个月前
已完结
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma
4个月前
已完结
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial
4个月前
已完结
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
4个月前
已完结
Immunotherapy in Anal Cancer
4个月前
已完结
Claudin 18.2 as a novel therapeutic target
4个月前
已完结
Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study
4个月前
已关闭
皖公网安备34019202002308
